Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1–34
J. Clin. Invest. Dengshun Miao, et al. 115:2402
doi:10.1172/JCI24918 [Go to this article.]

Problems with a PDF?